Nachrichten zur Moderna Inc. Aktie

Moderna anticipates 2027 release for cancer vaccine in collaboration with Merck By Investing.com

Moderna anticipates 2027 release for cancer vaccine in collaboration with Merck…

Biontech und Pfizer: Niederlage im Patentstreit mit Moderna

Moderna hat eine Klage gegen Pfizer und Biontech gewonnen. Das Unternehmen hatte den Konkurrenten vorgeworfen, Technologien kopiert zu haben. Die…

Moderna: Der CEO kauft für 5 Mio. USD Aktien. Bis 2027 sollen zehn neue Produkte auf den Markt kommen. Rebound-Chance!

Läuft es bei Moderna (MRNA) im Hintergrund gar nicht schlecht? Der Aktienkurs lässt mit seinem Dauerabsturz etwas anderes vermuten. Doch…

German court rules Pfizer, BioNTech infringed Moderna’s COVID-19 vaccine patent By Investing.com

German court rules Pfizer, BioNTech infringed Moderna’s COVID-19 vaccine patent…

German court rules Pfizer, BioNTech violated Moderna’s COVID-19 vaccine patent By Reuters

German court rules Pfizer, BioNTech violated Moderna’s COVID-19 vaccine patent…

German court rules Pfizer, BioNTech violated Modernas COVID-19 vaccine patent

A German court in Duesseldorf on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held…

Moderna shares jump on insider stock purchases

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares moved higher after it was disclosed the company insiders have purchased $6 million in shares.…

Moderna CEO Bancel buys ~$5M worth of company stock on open market

…

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a…

1 Biotech Stock to Buy in 2025, and 1 to Avoid

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.…

Eli Lillys big investment, cheaper Zepbound, and Hims & Hers options: Pharma news roundup

Plus, Modernas bird flu contract with the U.S. is being evaluated…

Why investors should stay away from Tesla and Moderna, according to one financial advisor

Courtney Garcia, senior wealth advisor at Payne Capital Management, appeared on CNBCs "Power Lunch" on Thursday to give hot takes on Tesla,…

Moderna Aktie: Einer der größten Verlierer

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Markus Bußler vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Can Modernas Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.…

Moderna: Mehr als nur COVID-19

Moderna hat sich mit seinem mRNA-Impfstoff gegen COVID-19 einen Namen gemacht, doch das Unternehmen arbeitet längst an einer breiteren…

Dow & Co unter Druck: UnitedHealth, Nvidia, Amazon, Rivian, Tesla schwach, Moderna, Alibaba stark

An den New Yorker Börsen hat sich am Freitag aufgrund von Konjunktur- und Inflationssorgen die Kursschwäche verfestigt. Der Leitindex Dow…

Dow & Co unter Druck: UnitedHealth, Nvidia, Amazon, Rivian, Tesla schwach, Moderna, Alibaba stark

An den New Yorker Börsen hat sich am Freitag aufgrund von Konjunktur- und Inflationssorgen die Kursschwäche verfestigt. Der Leitindex Dow…

Moderna stock rises amid new virus concerns By Investing.com

Moderna stock rises amid new virus concerns…

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.

In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than…

Moderna Aktie: Zwei bedeutende Rückschläge in der Medikamentenpipeline

Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse der Bank of America (BofA): 1. Hintergrund der Kurszielsenkung Die BofA hat das Kursziel für die Aktie von…

Moderna has limited upside: Barclays By Investing.com

Moderna has limited upside: Barclays…

Moderna shares move higher as investors look beyond Q4 losses

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares added more than 8% during Tuesday’s session as investors remained optimistic about the company’s long-term...…

Moderna shares move higher as investors look beyond Q4 losses to pipeline potential

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares added more than 8% during Tuesday’s session as investors remained optimistic about the company’s long-term...…

This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Hims & Hers Health (NYSE:HIMS), Datadog (NASDAQ:DDOG)

…

Moderna Aktie: Downgrade nach Q4-Zahlen!

London (www.aktiencheck.de) - Moderna-Aktienanalyse von Barclays: Rating und Kursziel Barclays hat die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF,…

Notable healthcare headlines for the week: J&J, CVS, Moderna, Biogen in focus

…

Moderna (MRNA) Q4 2024 Earnings Call Transcript

MRNA earnings call for the period ending December 31, 2024.…

Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline

MRNAs earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue guidance.…

Modernas Q4 Loss Wider Than Expected

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.…

Stocks making the biggest moves premarket: Moderna, Airbnb, GameStop, Roku and more

These are the stocks posting the largest moves in premarket trading.…

Moderna beats on revenue but loses more than expected as it scales down manufacturing

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from…

Moderna-Aktie nach schwacher Bilanz tiefrot

Das Biotechnologieunternehmen Moderna hat seine Ergebnisse für das vierte Quartal 2024 veröffentlicht.…

Moderna-Aktie unter Druck: Moderna kann mit tiefroter Bilanz nicht überzeugen

Im abgelaufenen Jahresviertel hat Moderna klare Verluste verzeichnet und je Aktie ein Minus von 2,91 US-Dollar erwirtschaftet. Zum Vorjahreswert von…

Moderna, Palo Alto and Applied Materials fall premarket; GameStop, Airbnb rise By Investing.com

Moderna, Palo Alto and Applied Materials fall premarket; GameStop, Airbnb rise…

Moderna shares rise on quarterly revenue beat despite wider-than-expected loss

Moderna Inc (NASDAQ:MRNA, ETR:0QF) stock moved higher after the pharmaceutical firm posted mixed results for the fourth quarter. It reported…

Moderna posts bigger loss than expected as vaccine maker scales down manufacturing

Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing…

DAX holt Luft, Gold stark: Siemens, Mercedes-Benz, VW, Porsche, Rheinmetall, BVB, Moderna im Fokus

Dem DAX ist am Donnerstag ein weiteres Rekordhoch gelungen. Die neue Bestmarke liegt nun bei 22.624,57 Punkten. Aus dem Handel…

U.S. stocks steady after weak retail sales; Moderna disappoints By Investing.com

U.S. stocks steady after weak retail sales; Moderna disappoints…

Moderna Aktie: Schwache Umsatzerwartungen belasten - Kursziel reduziert

Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities: Aktuelle Bewertung Tim Anderson von der Bank of America (BofA) hat das Kursziel für Moderna…

2 Biotech Stocks to Buy Hand Over Fist in February

Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the…

1 Stock to Buy, 1 Stock to Sell This Week: Robinhood, Moderna

…

3 Beaten-Down Stocks That Arent Worth Buying on the Dip

Buying stocks at significantly reduced valuations can lead to some incredible returns later on. But that doesnt mean that any…

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?

When MRNA reports fourth-quarter earnings, investors will likely focus on pipeline updates.…

3 Top AI-Powered Biotech Stocks to Buy in February

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technologys ability to automate complex…

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Amgen, CRISPR, Moderna, Sarepta and Vertex are included in this Analyst Blog.…

Vaccine stocks fall as Senate panel advances RFK Jr.s nomination for HHS secretary

Shares of Moderna, BioNTech, Novavax, GSK and Pfizer fell on Tuesday following the vote.…

Moderna Aktie: Kurszielsenkung

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von TD Cowen bewerten die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…

Moderna: The Good News Isnt Enough

…

Notable Healthcare headlines for the week: Moderna, AbbVie, Thermo Fisher, J&J in focus

…